Article

Dry eye sufferers may now consider LASIK procedure

New Orleans-Cyclosporine 0.05% ophthalmic emulsion (Restasis, Allergan) appears to be safe and effective in enhancing clinical outcomes in patients with dry eye who wish to undergo LASIK, said George M. Salib, MD.

Related Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
Related Content
MJH Life Sciences acquires EnVision Summit - ©dennisvdwater
October 9th 2024

MJH Life Sciences, parent of Ophthalmology Times, acquires EnVision Summit

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting
Published: October 9th 2024 | Updated: October 9th 2024

Verana Health debuts Qdata Explorer in advance of American Academy of Ophthalmology 2024 Annual Meeting

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Emmecell completes final patient visit in phase 1 EMME-001 trial of EO2002
October 9th 2024

Emmecell completes final patient visit in phase 1 EMME-001 trial of EO2002

Site Logo
October 8th 2024

Eyes on the Prize: Winning Strategies to Help Your Practice Thrive

© 2024 MJH Life Sciences

All rights reserved.